We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $6.16B
1-Year Est. Return 3.55%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+3.55%
3 Year Est. Return
+35.76%
5 Year Est. Return
+55.83%
10 Year Est. Return
+255.17%
AUM
$19B
AUM Growth
+$196M
Cap. Flow
-$1.65B
Cap. Flow %
-8.69%
Top 10 Hldgs %
54.61%
Holding
27
New
–
Increased
8
Reduced
17
Closed
2

Top Buys

Rank Stock Value
1
STT icon
State Street
STT
+$290M
2
WFC icon
Wells Fargo
WFC
+$227M
3
BNY
Bank of New York Mellon
BNY
+$135M
4
EMR icon
Emerson Electric
EMR
+$109M
5
GWW icon
W.W. Grainger
GWW
+$75.2M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$486M
2
DG icon
Dollar General
DG
+$478M
3
IQV icon
IQVIA
IQV
+$416M
4
PFE icon
Pfizer
PFE
+$372M
5
TMO icon
Thermo Fisher Scientific
TMO
+$332M

Sector Composition

Rank Sector Weight
1 Healthcare 28.67%
2 Financials 26.85%
3 Industrials 16.2%
4 Technology 12.96%
5 Communication Services 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$158B
– –
-8,993,825
Closed -$372M
TMO icon
27
Thermo Fisher Scientific
TMO
$227B
– –
-1,484,698
Closed -$332M
1
2

Similar funds

SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
SLI
Sumitomo Life Insurance Tokyo, Japan $6.12B AUM 21.82% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
EQF
Evergreen Quality Fund Grand Cayman, Cayman Islands $6.2B AUM 288.56% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Longview Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Longview Partners held 27 positions worth $19B, up 1% from $18.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Longview Partners withdrew a net $1.65B in Q1 2019, closing 2 positions and reducing 17 holdings. Its most notable exit was Pfizer, an estimated $372M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 37% a quarter earlier, followed by Financials and Industrials.

Against the trend, Longview Partners added an estimated $290M to State Street.

  • Longview Partners added most to State Street in Q1 2019, an estimated $290M increase.
  • Longview Partners's biggest Q1 2019 reduction was Zimmer Biomet, cutting an estimated $486M.
  • Longview Partners fully exited Pfizer in Q1 2019, selling an estimated $372M.
  • Longview Partners's ten largest holdings make up 55% of its $19B portfolio in Q1 2019.
  • Longview Partners opened 0 new positions and closed 2 in Q1 2019.
  • Longview Partners's portfolio value rose 1% quarter-over-quarter to $19B.

Based on Longview Partners's 13F filing for Q1 2019, filed 15 May 2019.